SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-24-066784
Filing Date
2024-05-30
Accepted
2024-05-30 20:05:17
Documents
2
Period of Report
2024-05-28

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2415914-1_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2415914-1_3seq1.xml 3 1630
2 EXHIBIT 24 tm2415914d1_ex24.htm EX-24 6554
  Complete submission text file 0001104659-24-066784.txt   9800
Mailing Address 221 CRESCENT ST. BUILDING 17, SUITE 102B WALTHAM MA 02453
Business Address 221 CRESCENT ST. BUILDING 17, SUITE 102B WALTHAM MA 02453 650-394-5230
Apogee Therapeutics, Inc. (Issuer) CIK: 0001974640 (see all company filings)

IRS No.: 934958665 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O APOGEE THERAPEUTICS, INC. 221 CRESCENT ST.,BUILDING 17, SUITE 102B WALTHAM MA 02453
Business Address
Bollinger Lisa (Reporting) CIK: 0002024557 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-41740 | Film No.: 241007235